![Steven Glazer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Glazer
Directeur Technique/Scientifique/R&D chez
Glazer Consulting Holding ApS
Profil
Steven Glazer is currently the Chief Medical Officer at MonTa Biosciences ApS, Allero Therapeutics BV, and Glazer Consulting Holding ApS.
Previously, he worked as the Medical Director at Novo Nordisk Scandinavia AB, Independent Director at Mendus AB, Medical Director at RhoVac AB, Senior Vice President-Development at BioInvent International AB, Vice President-Development at Zealand Pharma A, Chief Medical Officer & Vice President at Hansa Biopharma AB, Chief Marketing Officer at Idogen AB, and Chief Medical Officer at Ectin Research AB. He holds a doctorate degree from the University of Copenhagen.
Postes actifs de Steven Glazer
| Sociétés | Poste | Début |
|---|---|---|
Glazer Consulting Holding ApS | Directeur Technique/Scientifique/R&D | - |
MonTa Biosciences ApS
 MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Directeur Technique/Scientifique/R&D | - |
Allero Therapeutics BV
 Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Steven Glazer
| Sociétés | Poste | Fin |
|---|---|---|
| CHOSA ONCOLOGY AB | Corporate Officer/Principal | - |
Idogen AB
 Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Sales & Marketing | - |
| ECTIN RESEARCH AB | Directeur Technique/Scientifique/R&D | - |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services | Directeur Technique/Scientifique/R&D | - |
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
Formation de Steven Glazer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
BioInvent International AB
 BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services | Health Technology |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Health Technology |
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology Engages in the research and development of immunotherapy for therapeutic cancer vaccines | Health Technology |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Health Technology |
Ectin Research AB
 Ectin Research AB BiotechnologyHealth Technology Provides cancer therapy research services | Health Technology |
Allero Therapeutics BV
Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases | Commercial Services |
Glazer Consulting Holding ApS |
